Zeo ScientifiX, Inc.: enters strategic agreement with Pluri Inc.

What happened Zeo ScientifiX, Inc. reported that on Oct 26, 2026 it and Pluri Inc. (Nasdaq and TASE: PLUR) announced they entered into a definitive strategic agreement to expand the parties’ U.S. manufacturing and commercialization platform serving the regenerative medicine, aesthetics, wellness, and longevity markets. The company included a copy of the joint press release as Exhibit 99.1 to the Report.

Key details

• Agreement announced on Oct 26, 2026 between Zeo ScientifiX, Inc. and Pluri Inc. (Nasdaq and TASE: PLUR).
• Purpose described as expanding the parties’ U.S. manufacturing and commercialization platform.
• Press release documenting the announcement is included as Exhibit 99.1 to the Form 8-K.
• Item reported on the Form 8-K: Item 1.01, entry into a material definitive agreement.

Why it may matter

• The filing reports Item 1.01, which covers entry into a material definitive agreement between the companies.
  This filing does not show why the insider traded or why the company acted.